SCHEMBL24815670

SCHEMBL24815670

O=C(CS(=O)(=O)c1nccs1)N1Cc2cc(Cl)c(Cl)cc2C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NLRP3 Q96P20 1/20 0.35
▸ LMNA P02545 4/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ GRM5 P41594 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ KAT8 Q9H7Z6 1/20 0.32
▸ ACP1 P24666 1/20 0.32
▸ TRPV4 Q9HBA0 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ USP2 O75604 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ GAA P10253 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ GRIN2B Q13224 1/20 0.31
▸ NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24817127 0.88 MAOB (0.40) LMNAALDH1A1MEN1KMT2AGRM5
SCHEMBL24814740 0.88 NLRP3 (0.35) NLRP3KAT8ACP1SMN1; SMN2NPC1
SCHEMBL29987551 0.87 MAOB (0.39) NLRP3LMNAGRM5ESR2SMN1; SMN2
SCHEMBL24815669 0.85 SMN1; SMN2 (0.42) LMNAALDH1A1SMN1; SMN2NPC1
SCHEMBL29986905 0.85 SMN1; SMN2 (0.42) LMNAALDH1A1SMN1; SMN2NPC1
SCHEMBL26845908 0.83 DPP8 (0.40) LMNAALDH1A1MEN1KMT2AHSD17B10
SCHEMBL24817122 0.83 NAMPT (0.44) —
SCHEMBL24814391 0.82 RYR2 (0.43) LMNAALDH1A1HTTMAPTUSP2
SCHEMBL24814401 0.80 DPP7 (0.43) LMNAMEN1KMT2AMAPTSMN1; SMN2
SCHEMBL24815798 0.79 NAMPT (0.42) ALDH1A1KMT2AMAPK1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed
WO-2022251343-A2 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH NLRP3 3821/4885LMNA 4440/4885ALDH1A1 3533/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH NLRP3 3821/4885LMNA 4440/4885ALDH1A1 3533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback